Arvest Bank Trust Division’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.48M | Sell |
52,767
-1,688
| -3% | -$44.9K | 0.08% | 116 |
|
|
2025
Q4 | $1.36M | Sell |
54,455
-872
| -2% | -$22K | 0.07% | 112 |
|
|
2025
Q3 | $1.41M | Sell |
55,327
-1,392
| -2% | -$34.4K | 0.08% | 112 |
|
|
2025
Q2 | $1.37M | Sell |
56,719
-16,695
| -23% | -$389K | 0.08% | 105 |
|
|
2025
Q1 | $1.86M | Sell |
73,414
-403,291
| -85% | -$10.6M | 0.12% | 94 |
|
|
2024
Q4 | $12.6M | Sell |
476,705
-8,438
| -2% | -$229K | 0.76% | 42 |
|
|
2024
Q3 | $14M | Buy |
+485,143
| New | +$14.2M | 0.81% | 43 |
|
|
2021
Q3 | $15.2M | Sell |
353,458
-792
| -0.2% | -$35.1K | 0.85% | 39 |
|
|
2021
Q2 | $13.9M | Sell |
354,250
-5,280
| -1% | -$205K | 0.76% | 42 |
|
|
2021
Q1 | $13M | Sell |
359,530
-5,329
| -1% | -$189K | 0.76% | 41 |
|
|
2020
Q4 | $13.4M | Buy |
364,859
+3,073
| +0.8% | +$113K | 0.83% | 35 |
|
|
2020
Q3 | $12.6M | Sell |
361,786
-14,765
| -4% | -$518K | 0.9% | 35 |
|
|
2020
Q2 | $11.7M | Sell |
376,551
-248
| -0.1% | -$8.43K | 0.86% | 37 |
|
|
2020
Q1 | $11.7M | Sell |
376,799
-41,101
| -10% | -$1.4M | 1.08% | 34 |
|
|
2019
Q4 | $15.5M | Sell |
417,900
-6,700
| -2% | -$239K | 1% | 33 |
|
|
2019
Q3 | $14.5M | Sell |
424,600
-11,881
| -3% | -$432K | 0.99% | 35 |
|
|
2019
Q2 | $17.9M | Sell |
436,481
-8,885
| -2% | -$353K | 1.23% | 27 |
|
|
2019
Q1 | $17.9M | Sell |
445,366
-3,092
| -0.7% | -$124K | 1.24% | 26 |
|
|
2018
Q4 | $18.6M | Sell |
448,458
-1,157
| -0.3% | -$48K | 1.48% | 18 |
|
|
2018
Q3 | $18.8M | Sell |
449,615
-6,229
| -1% | -$240K | 1.27% | 24 |
|
|
2018
Q2 | $15.7M | Sell |
455,844
-5,160
| -1% | -$176K | 1.12% | 30 |
|
|
2018
Q1 | $15.5M | Sell |
461,004
-5,253
| -1% | -$181K | 1.1% | 33 |
|
|
2017
Q4 | $16M | Sell |
466,257
-15,560
| -3% | -$531K | 1.12% | 32 |
|
|
2017
Q3 | $16.3M | Buy |
481,817
+4,545
| +1% | +$146K | 1.16% | 31 |
|
|
2017
Q2 | $15.2M | Buy |
477,272
+5,884
| +1% | +$186K | 1.15% | 31 |
|
|
2017
Q1 | $15.3M | Sell |
471,388
-13,550
| -3% | -$427K | 1.2% | 30 |
|
|
2016
Q4 | $14.9M | Sell |
484,938
-8,776
| -2% | -$268K | 1.2% | 32 |
|
|
2016
Q3 | $15.9M | Sell |
493,714
-1,892
| -0.4% | -$63.3K | 1.32% | 23 |
|
|
2016
Q2 | $16.6M | Buy |
495,606
+3,536
| +0.7% | +$113K | 1.42% | 21 |
|
|
2016
Q1 | $13.8M | Buy |
492,070
+12,612
| +3% | +$360K | 1.17% | 33 |
|
|
2015
Q4 | $14.7M | Sell |
479,458
-4,476
| -0.9% | -$141K | 1.28% | 30 |
|
|
2015
Q3 | $14.4M | Buy |
483,934
+10,981
| +2% | +$352K | 1.3% | 28 |
|
|
2015
Q2 | $15M | Buy |
472,953
+2,708
| +0.6% | +$88.3K | 1.27% | 31 |
|
|
2015
Q1 | $15.5M | Buy |
470,245
+3,972
| +0.9% | +$126K | 1.33% | 28 |
|
|
2014
Q4 | $13.8M | Buy |
466,273
+5,948
| +1% | +$171K | 1.21% | 38 |
|
|
2014
Q3 | $12.9M | Buy |
+460,325
| New | +$12.9M | 1.19% | 39 |
|
Other funds holding PFE
VCM
VPM
Arvest Bank Trust Division's PFE Position: Q1 2026 in Review
Arvest Bank Trust Division reduced its Pfizer (PFE) stake by 3.1% in Q1 2026, selling an estimated $44.9K and leaving 52,767 shares worth $1.48M. The position accounts for 0.08% of the portfolio, ranked #116.
Arvest Bank Trust Division first reported a position in PFE in Q3 2014 and has held it in 36 quarters since. The position peaked at $18.8M in Q3 2018. 2,939 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- Arvest Bank Trust Division held 52,767 shares of Pfizer worth $1.48M as of Q1 2026.
- Arvest Bank Trust Division sold 1,688 Pfizer shares in Q1 2026, an estimated $44.9K.
- Pfizer made up 0.08% of Arvest Bank Trust Division's portfolio in Q1 2026, its #116 holding.
- Arvest Bank Trust Division first reported a position in Pfizer in Q3 2014 and has held it in 36 quarters since.
- Arvest Bank Trust Division's Pfizer position peaked at $18.8M in Q3 2018.
- 2,939 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on Arvest Bank Trust Division's 13F filing for Q1 2026, filed 13 May 2026.